×
About 46,758 results

ALLMedicine™ Abdominal Pain Center

Research & Reviews  13,667 results

Complementary and Integrative Medicine in Pancreatic Cancer.
https://doi.org/10.1007/s11912-023-01370-z
Current Oncology Reports; Frenkel M, David A et. al.

Feb 4th, 2023 - Pancreatic cancer has high mortality and morbidity rates, associated with the issues of typically late diagnosis and the limited effectiveness of current treatments. Patients tend to experience multiple symptoms that can include anxiety, fear, dep...

Randomised clinical trial: Psychological intervention improves work productivity and da...
https://doi.org/10.1111/apt.17399
Alimentary Pharmacology & Therapeutics; Regev S, Schwartz D et. al.

Feb 4th, 2023 - Chronic abdominal pain and fatigue are characteristics of Crohn's disease (CD) and contribute to functional impairments. To examine whether CD-tailored cognitive-behavioural and mindfulness intervention (COBMINDEX) is effective in reducing abdomin...

Five-year results of spontaneous isolated superior mesenteric artery dissection from tw...
https://doi.org/10.1016/j.avsg.2023.01.019
Annals of Vascular Surgery; Lian LS, Wu ZY et. al.

Feb 4th, 2023 - To present five-year results of management on spontaneous isolated superior mesenteric artery dissection (SISMAD) from two teaching hospitals in China. The clinical data of 41 patients with SISMAD were retrospectively collected from two teaching h...

62-Year-Old Man With Abdominal Pain.
https://doi.org/10.1016/j.mayocp.2022.06.033
Mayo Clinic Proceedings; Dunn R, Sahni N

Feb 4th, 2023 - 62-Year-Old Man With Abdominal Pain.|2023|Dunn R,Sahni N,|

Pediatric Pneumonia
http://emedicine.medscape.com/article/967822-overview

Feb 3rd, 2023 - Practice Essentials Pediatric pneumonia is responsible for the deaths of more than 800,000 young children worldwide each year, according to the United Nations Children's Fund (UNICEF). [1] These deaths occur almost exclusively in children with und...

see more →

Guidelines  21 results

AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: E...
https://doi.org/10.1053/j.gastro.2022.11.034
Gastroenterology Wang B, Bonkovsky HL et. al.

Jan 16th, 2023 - The acute hepatic porphyrias (AHP) are rare, inborn errors of heme-metabolism and include acute intermittent porphyria, hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of 5-aminolevulinic acid dehydratase. Ac...

ACR Appropriateness Criteria® Right Lower Quadrant Pain: 2022 Update.
https://doi.org/10.1016/j.jacr.2022.09.011
Journal of the American College of Radiology : JACR; , Kambadakone AR et. al.

Nov 28th, 2022 - This document focuses on imaging in the adult and pregnant populations with right lower quadrant (RLQ) abdominal pain, including patients with fever and leukocytosis. Appendicitis remains the most common surgical pathology responsible for RLQ abdo...

Operative management of acute abdomen after bariatric surgery in the emergency setting:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516804
World Journal of Emergency Surgery : WJES; De Simone B, Chouillard E et. al.

Sep 28th, 2022 - Patients presenting with acute abdominal pain that occurs after months or years following bariatric surgery may present for assessment and management in the local emergency units. Due to the large variety of surgical bariatric techniques, emergenc...

Blinded Oral Challenges with Lactose and Placebo Accurately Diagnose Lactose Intolerance: A Real-Life Study
https://pubmed.ncbi.nlm.nih.gov/34068318/
Nutrients Rocco A, Compare D et. al.

May 13th, 2021 - Lactose intolerance (LI) is characterized by diarrhea, abdominal pain, or bloating occurring after lactose consumption in patients with lactose malabsorption. The National Institute of Health (NIH) proposed a double-blind placebo testing to identi...

Chronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular...
https://doi.org/10.1016/j.jvs.2020.10.029
Journal of Vascular Surgery; Huber TS, Björck M et. al.

Nov 11th, 2020 - Chronic mesenteric ischemia (CMI) results from the inability to achieve adequate postprandial intestinal blood flow, usually from atherosclerotic occlusive disease at the origins of the mesenteric vessels. Patients typically present with postprand...

see more →

Drugs  702 results see all →

Clinicaltrials.gov  1,176 results

Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel
https://clinicaltrials.gov/ct2/show/NCT04605783

Feb 2nd, 2023 - Probiotics and passive immunoprophylaxis are classes of dietary supplements that are lawfully marketed in the US for maintenance of gut health (GH). This randomized, double-blind, clinical trial will evaluate one commercially available dietary sup...

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
https://clinicaltrials.gov/ct2/show/NCT05509725

Feb 2nd, 2023 - To monitor safety and to evaluate the efficacy of a probiotic formulation on severity of gastrointestinal symptoms (abdominal pain, abnormal defecation), anxiety, depression and quality of life in adult participants with IBS-D.

Sexual Function and Quality of Life Among Patients Suffering From Inflammatory Bowel Disease
https://clinicaltrials.gov/ct2/show/NCT05707429

Feb 1st, 2023 - Inflammatory Bowel Diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are characterized by a chronically relapsing course (1). IBD is likely to have a substantial impact on body image, intimacy and sexuality, Because of symptoms lik...

High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population
https://clinicaltrials.gov/ct2/show/NCT05342532

Feb 1st, 2023 - All patients, at least 18 years of age, with a chief complaint of dyspepsia and documented treatment-naïve HP infection diagnosed on UBT, esophagogastroduodenoscopy (EGD) with HP biopsy, or SAT were recruited for the study. Dyspepsia was defined a...

Efficacy and Safety of Two Doses of HIL-214 in Children
https://clinicaltrials.gov/ct2/show/NCT05281094

Feb 1st, 2023 - Noroviruses have emerged as the single most significant cause of gastroenteritis in both middle-high income countries and low resource settings worldwide. Those most at risk of severe illness include the very young, the elderly and immunocompromis...

see more →

News  2,778 results

First Oral Treatment for CKD Anemia OK'd for Patients on Dialysis
https://www.medpagetoday.com/nephrology/anemia/102928

Feb 2nd, 2023 - The FDA approved the first oral agent for chronic kidney disease (CKD)-related anemia for adults on dialysis, the agency announced late on Wednesday. Daprodustat (Jesduvroq) is a once-daily tablet specifically indicated for patients who have been ...

Acute hepatic porphyrias no longer as rare as previously thought
https://www.mdedge.com/internalmedicine/article/260911/gastroenterology/acute-hepatic-porphyrias-no-longer-rare-previously
Carolyn Crist

Jan 30th, 2023 - Although rare, acute hepatic porphyrias (AHPs) may be more common than previously thought, particularly among women between ages 15 and 50, according to a new clinical practice update from the American Gastroenterological Association. For acute at.

FDA Greenlights First Drug for ESR1-Mutated Breast Cancer
https://www.medpagetoday.com/hematologyoncology/breastcancer/102880

Jan 30th, 2023 - The FDA approved the selective estrogen receptor (ER) degrader elacestrant (Orserdu) for the treatment of postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression...

Proof lacking for dual-targeted therapy benefit in IBD
https://www.mdedge.com/internalmedicine/article/260796/gastroenterology/proof-lacking-dual-targeted-therapy-benefit-ibd
Neil Osterweil

Jan 25th, 2023 - AURORA, COLO. – Only sparse evidence supports the use of dual-targeted therapy for patients with severe, refractory inflammatory bowel disease (IBD) -- and additional evidence will be hard to come by, according to a leading IBD researcher.

Medication-induced rhabdomyolysis in a patient with bipolar disorder
https://www.mdedge.com/psychiatry/article/260760/bipolar-disorder/medication-induced-rhabdomyolysis-patient-bipolar
Jayasudha Gude, MD, Viwek Bisen, DO et. al.

Jan 24th, 2023 - Editor’s note: Readers’ Forum is a department for correspondence from readers that is not in response to articles published in Current Psychiatry. All submissions to Readers’ Forum undergo peer review and are subject to editing for length and styl.

see more →

Patient Education  359 results see all →